Carcinoid Tumor
Carcinoid Tumor is a neuroendocrine cancer that may affect the gut or lungs. Learn symptoms, diagnosis, treatment and when to seek care.

Quick answer
A carcinoid tumor is a slow-growing neuroendocrine tumor that usually starts in the digestive tract or lungs and may produce hormones that cause symptoms such as flushing or diarrhea. At Acibadem in Turkey, evaluation focuses on imaging, laboratory tests, endoscopy, and pathology, and treatment is planned by a multidisciplinary team using surgery, medical therapies, and other targeted approaches according to…
A carcinoid tumor is a type of neuroendocrine tumor that starts in hormone-producing cells, most often in the digestive tract or lungs. Many carcinoid tumors grow slowly, but they still require specialist assessment because they can spread or produce hormone-related symptoms.
Overview
A carcinoid tumor is a type of neuroendocrine tumor, also called a NET, that develops from specialized cells with both nerve-like and hormone-producing features. These cells are found throughout the body, but carcinoid tumors most commonly arise in the gastrointestinal tract, including the small intestine, appendix, rectum and stomach, or in the lungs.
The word carcinoid is an older term that remains familiar to many patients and doctors. In modern oncology, many of these tumors are described more precisely as well-differentiated neuroendocrine tumors. “Well-differentiated” means the tumor cells still resemble the original neuroendocrine cells under the microscope, which often reflects a slower-growing behavior than many other cancers.
Carcinoid tumors can behave very differently from one person to another. Some are small and discovered incidentally during scans, endoscopy or surgery for another reason. Others may grow, spread to lymph nodes or the liver, or release hormone-like substances that cause symptoms such as flushing, diarrhea or wheezing, known as carcinoid syndrome.
Symptoms
Carcinoid tumor symptoms depend on where the tumor is located, whether it has spread, and whether it releases hormones into the bloodstream. Many early or small carcinoid tumors cause no symptoms at all. When symptoms do occur, they can be vague and may resemble more common digestive, respiratory or hormonal conditions.
Possible symptoms include:
- Abdominal pain, cramping, bloating or discomfort
- Changes in bowel habits, including diarrhea or constipation
- Unexplained nausea, vomiting or weight loss
- Rectal bleeding or blood in the stool, depending on tumor location
- Cough, wheezing, shortness of breath or repeated chest infections when the tumor is in the lung
- Facial flushing, warmth, sweating, fast heartbeat or diarrhea related to carcinoid syndrome
Carcinoid syndrome usually occurs when hormone-like substances made by the tumor reach the general circulation, most often when disease has spread to the liver. Not every carcinoid tumor causes this syndrome. Symptoms can be intermittent, and some people notice that flushing or diarrhea is triggered by alcohol, stress, certain foods or exertion.
Causes & Risk Factors
In most people, the exact cause of a carcinoid tumor is not known. Like other cancers, it develops when genetic changes in a cell allow it to grow and divide in an uncontrolled way. These changes usually occur during a person’s lifetime and are not necessarily inherited from parents.
Several factors may increase risk, although having a risk factor does not mean a person will develop a carcinoid tumor. Some neuroendocrine tumors are associated with inherited syndromes such as multiple endocrine neoplasia type 1. A family history of certain endocrine tumors, long-standing conditions that affect stomach acid production, and some chronic stomach conditions may also be relevant in selected cases.
Risk patterns can differ by tumor site. Lung carcinoid tumors may be more common in people with a history of smoking, although they can also occur in people who have never smoked. Age, sex and ethnicity may influence risk in some populations, but carcinoid tumors remain relatively uncommon overall. A doctor can interpret personal risk in context rather than relying on any single factor.
Diagnosis
Diagnosis of a carcinoid tumor begins with a medical history, physical examination and review of symptoms. The doctor may ask about flushing, diarrhea, wheezing, abdominal pain, bowel changes, weight loss, medications, family history and any previous imaging or endoscopy results. Because symptoms can be nonspecific, diagnosis sometimes takes time and often involves several tests.
Common diagnostic tools include blood and urine tests that look for substances produced by neuroendocrine tumors or their breakdown products. For suspected carcinoid syndrome, a 24-hour urine test for 5-HIAA may be used in appropriate patients. Blood markers can support the evaluation, but they are not perfect on their own and may be affected by diet, medications or other medical conditions.
Imaging helps locate the tumor and check whether it has spread. This may include CT, MRI, ultrasound, or specialized nuclear medicine scans that detect somatostatin receptors on neuroendocrine tumor cells. Endoscopy, colonoscopy, bronchoscopy or capsule-based tests may be recommended depending on the suspected site. A biopsy, when feasible, confirms the diagnosis and allows pathologists to assess tumor grade, including markers such as Ki-67, which helps guide treatment planning.
Treatment Options
Treatment for a carcinoid tumor is individualized. The right approach is decided by a specialist team after assessing the tumor’s location, size, stage, grade, growth rate, hormone activity, symptoms and the person’s overall health. A multidisciplinary team may include medical oncologists, surgeons, gastroenterologists, pulmonologists, endocrinologists, radiologists, nuclear medicine specialists, pathologists and specialist nurses.
Surgery is often considered when the tumor can be removed safely, especially for localized disease. Surgery may involve removing the tumor and nearby lymph nodes, or treating complications such as bowel blockage. In selected cases where disease has spread to the liver, surgery or local liver-directed procedures may be considered to reduce tumor burden or control symptoms.
Medication-based treatments may help control hormone-related symptoms and may also slow tumor activity in some cases. Other systemic options can include targeted therapy, peptide receptor radionuclide therapy for tumors with suitable receptor expression, or chemotherapy in selected tumors, particularly those with more aggressive features. Radiotherapy may be used in specific circumstances, such as symptom control or treatment of certain metastases.
Supportive care is an important part of treatment. This may include managing diarrhea, wheezing, nutritional problems, pain, anxiety, treatment side effects and overall wellbeing. Patients should not start supplements, special diets or over-the-counter medicines for carcinoid symptoms without discussing them with their doctor, because some products can interact with treatment or affect test results.
Living With / Prognosis
Many people with carcinoid tumors live with the condition for years, especially when the tumor is slow-growing and monitored carefully. Prognosis depends on several factors, including where the tumor started, whether it has spread, how quickly it is growing, whether it produces hormones, and how completely it can be treated. For this reason, the outlook is best discussed with the treating specialist, who can interpret the individual medical details.
Follow-up is usually long term. Even after treatment, doctors may recommend periodic imaging, blood or urine tests, symptom reviews and sometimes endoscopy, depending on the original tumor site and risk of recurrence. Keeping scheduled appointments is important because changes can sometimes be detected before symptoms become noticeable.
Daily life can often be supported with practical measures such as tracking symptoms, noting possible flushing or diarrhea triggers, maintaining hydration, eating a balanced diet and reporting new symptoms promptly. People with carcinoid syndrome may receive specific guidance about procedures, anesthesia and symptom control because hormone release can occasionally need special preparation in medical settings.
For international patients seeking evaluation, Acibadem International provides multidisciplinary diagnosis and treatment for carcinoid tumors in JCI-accredited hospitals. Care decisions should always be based on a full specialist assessment and clear discussion of benefits, risks and alternatives.
When to See a Doctor
A person should see a doctor if they have persistent or unexplained symptoms such as ongoing abdominal pain, repeated diarrhea, unexplained weight loss, blood in the stool, persistent cough or wheezing, recurrent flushing, or episodes of rapid heartbeat and faintness. These symptoms do not necessarily mean carcinoid tumor, but they deserve medical evaluation, especially if they continue or worsen.
People already diagnosed with a carcinoid tumor should contact their care team if symptoms change, new symptoms appear, or treatment side effects become difficult to manage. Prompt communication helps the team adjust testing, supportive care or treatment when needed.
Urgent medical care is appropriate for severe shortness of breath, chest pain, fainting, black or heavy bloody stools, severe dehydration, persistent vomiting, or sudden severe abdominal pain. These situations can have many causes and need timely assessment by qualified medical professionals.
Frequently asked questions
What is a carcinoid tumor?
A carcinoid tumor is a type of neuroendocrine tumor that starts in cells capable of producing hormone-like substances. It most often develops in the digestive tract or lungs. Many carcinoid tumors grow slowly, but they still need expert evaluation because they can spread or cause hormone-related symptoms.
Is a carcinoid tumor cancer?
Yes, a carcinoid tumor is generally considered a cancerous neuroendocrine tumor, although many are slow-growing. Its behavior can range from very indolent to more active, depending on the tumor site, grade and stage. A biopsy and imaging tests help doctors understand how it is likely to behave.
What is carcinoid syndrome?
Carcinoid syndrome is a group of symptoms caused by hormone-like substances released by some carcinoid tumors. It may cause flushing, diarrhea, wheezing, abdominal cramping or a fast heartbeat. It is more likely when tumor substances reach the bloodstream, often in cases with liver involvement.
How is a carcinoid tumor diagnosed?
Diagnosis usually involves a combination of medical history, physical examination, blood or urine tests, imaging and biopsy. Depending on the suspected location, endoscopy, colonoscopy or bronchoscopy may be used. The biopsy helps confirm the tumor type and grade, which are important for treatment planning.
Can a carcinoid tumor be removed with surgery?
Some carcinoid tumors can be removed surgically, especially when they are localized and can be safely accessed. Surgery may also be considered in selected cases to reduce tumor burden or manage complications. Whether surgery is appropriate depends on tumor location, spread, overall health and specialist assessment.
What treatments are available for carcinoid tumor?
Treatment options may include surgery, medicines to control hormone symptoms, targeted therapies, peptide receptor radionuclide therapy, liver-directed treatments, radiotherapy or chemotherapy in selected situations. The correct approach is not the same for everyone. A specialist team decides the plan after reviewing tumor features, symptoms and the patient’s overall condition.
Can people live well with a carcinoid tumor?
Many people with carcinoid tumors can maintain good quality of life with appropriate monitoring and treatment. Long-term follow-up is often needed because these tumors can grow slowly and change over time. Regular communication with the care team helps manage symptoms, treatment effects and future planning.
References
- World Health Organization
- National Cancer Institute
- European Society for Medical Oncology
- North American Neuroendocrine Tumor Society
- National Comprehensive Cancer Network
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Treatments for This Condition
Doctors Who Treat This Condition

Prof. Dr. Abdullah Büyükçelik
Medical Oncology
Prof. Dr. Ali Arican
Medical Oncology
Prof. Dr. Aziz Yazar
Medical Oncology
Prof. Dr. Başak Oyan Uluç
Medical Oncology
Prof. Dr. Bülent Karabulut
Medical Oncology
Prof. Dr. Ersin Özaslan
Medical Oncology
Prof. Dr. Faysal Dane
Medical Oncology
Prof. Dr. Gökhan Demir
Medical Oncology
Prof. Dr. Gül Başaran
Medical Oncology
Prof. Dr. Handan Onur Topuzlu
Medical Oncology
Prof. Dr. Hüseyin Engin
Medical Oncology
